Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaferon in Chinese patients with multiple sclerosis
2014-004613-93Phase 3
- Sponsor
- Bayer
- Start
- Jan 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Bayer. Primary endpoint: Primary efficacy endpoint.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2014-004613-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004613-93.